The University of Chicago Header Logo

Connection

David Grinblatt to Proteasome Inhibitors

Back to Details
This is a "connection" page, showing publications David Grinblatt has written about Proteasome Inhibitors.
David Grinblatt
Connection Strength
0.051
Proteasome Inhibitors
  1. Elotuzumab and Weekly Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Without Transplant Intent: A Phase 2 Measurable Residual Disease-Adapted Study. JAMA Oncol. 2022 09 01; 8(9):1278-1286.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.